Wnt5a enhanced vasculogenic mimicry, EMT, migration, and invasiveness of ovarian cancer cells in a PKCα-dependent manner, and inhibition of PKCα blocked these effects [224]. This evidence concerns the gene WNT5A and ovarian carcinoma.